Skip to main content
# Title Department Research Year
871 Innovative HPTLC Method with Fluorescence Detection for Assessment of Febuxostat-Montelukast Combination and Study of Their Protective Effects Against Gouty Arthritis Department of Pharmaceutical Analytical Chemistry 2018
872 A Localized Surface Plasmon Resonance Sensing Method for Simultaneous Determination of Atenolol and Amiloride in Pharmaceutical Dosage Forms and Urine Samples Department of Pharmaceutical Analytical Chemistry 2018
873 Novel N-Substituted 5-aminosalicylamides as Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase Enzymes: Synthesis, Biological Evaluation and Docking Study Department of Pharmaceutical Organic Chemistry 2018
874 Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits Department of Pharmaceutical Analytical Chemistry 2018
875 Optimization of siRNA delivery to target sites: issues and future directions Department of Pharmaceutics 2018
876 Enhanced dispersive solid phase extraction assisted
by cloud point strategy prior to fluorometric
determination of anti-hepatitis C drug velpatasvir in
pharmaceutical tablets and body fluids
Department of Pharmaceutical Analytical Chemistry 2018
877 Efficient HPTLC-dual wavelength spectrodensitometric method for simultaneous determination of sofosbuvir and daclatasvir: Biological and pharmaceutical analysis Department of Pharmaceutical Analytical Chemistry 2018
878 Novel Targeted Lipid Nanoparticles Loaded with Synergistic Chemotherapy- Gene therapy Combination for Effective Treatment of Hepatocellular Carcinoma Department of Pharmaceutics 2018
879 Self-Emulsifying Drug-Delivery Systems Modulate P-Glycoprotein Activity: Role of Excipients and Formulation Aspects Department of Pharmaceutics 2018
880 Fluorimetric determination of febuxostat in dosage forms and in real human plasma via Förster resonance energy transfer‏ Department of Pharmaceutical Analytical Chemistry 2018